Health researchers working with DENT Neurologic Institute, Jamaica pharmaceutical company to increase global clinical research.

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

Pharmaceutical Contract Manufacturing Market Growth is Driven by Rising Demand for Cost-Effective Drug Production and Technological Advancements.Pune, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Pharmaceutical ...

Total revenue, driven primarily from sales of Illuccix® of $783.2 million, up by 56% 1 from $502.5 million in 2023, beating full year guidance 2. R&D investment of $194.6 million, in line with ...

The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in ...

Orchid Pharma's Alathur API facility successfully completes US FDA inspection: Our Bureau, Mumbai Thursday, February 20, 2025, 11:30 Hrs [IST] Orchid Pharma Ltd., a vertically int ...

Orchid Pharma added 1.96% to Rs 851 after company completed an inspection by the U.S. Food and Drug Administration (USFDA) at its active pharmaceutical ingredient (API) manufacturing facility in ...

Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosporins, a ...

The inspection, which commenced on 10 February 2025 and concluded on 18 February 2025, resulted in seven minor observations, ...